title: [Primary fallopian tube carcinoma].
abstract: BACKGROUND
  Primary fallopian tube carcinoma is extremely rare, making 0.3-1.6% of all female genital tract malignancies. Although the etymology of this tumor is unknown, it is suggested to be associated with chronic tubal inflammation, infertility, tuberculous salpingitis and tubal endometriosis. High parity is considered to be protective. Cytogenetic studies show the disease to be associated with over expression of p53, HER2/neu and c-myb. There is also some evidence that BRCA1 and BRCA2 mutations have a role in umorogeneis.
  
  
  METHODS
  The most prevailing symptoms with fallopian tube carcinoma are abdominal pain, abnormal vaginal discharge/bleeding and the most common finding is an adnexal mass. In many patients, fallopian tube carcinoma is asymptomatic.
  
  
  METHODS
  Due to its rarity, preoperative diagnosis of primary fallopian tube carcinoma is rarely made. It is usually misdiagnosed as ovarian carcinoma, tuboovarian abscess or ectopic pregnancy. Sonographic features of the tumor are non-specific and include the presence of a fluid-filled adnexal structure with a significant solid component, a sausage-shaped mass, a cystic mass with papillary projections within, a cystic mass with cog wheel appearance and an ovoid-shaped structure containing an incomplete separation and a highly vascular solid nodule. More than 80% of patients have elevated pretreatment serum CA-125 levels, which is useful in follow-up after the definite treatment.
  
  
  METHODS
  The treatment approach is similar to that of ovarian carcinoma, and includes total abdominal hysterectomy and bilateral salpingo-oophorectomy. Staging is followed with chemotherapy.
authors.affiliation: Klinika za ginekologiju i akuserstvo, Klinicki centar Vojvodine, Novi Sad.
authors.forename: Ljiljana
authors.initials: L
authors.lastname: Mladenović-Segedi
mesh_terms: D002277:Carcinoma / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D005185:Fallopian Tube Neoplasms / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D005260:Female; D006801:Humans